Prasugrel Single Antiplatelet Therapy versus Aspirin and Clopidogrel Dual Antiplatelet Therapy for Flow Diverter Treatment for Cerebral Aneurysms: A Retrospective Multicenter Study.
Sophia HohenstattIşıl SaatciJessica JesserH Saruhan CekirgeNaci KocerCivan IşlakHannes LückingJohannes DuPlessisRiitta RautioMartin BendszusDominik F VollherbstMarkus Alfred MöhlenbruchPublished in: AJNR. American journal of neuroradiology (2024)
Prasugrel single antiplatelet therapy after flow diverter treatment may be as safe and effective as dual antiplatelet therapy and could, therefore, be a valid alternative in selected patients. Further prospective comparative studies are required to validate our findings.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- acute coronary syndrome
- coronary artery disease
- end stage renal disease
- chronic kidney disease
- ejection fraction
- internal carotid artery
- newly diagnosed
- atrial fibrillation
- low dose
- type diabetes
- cardiovascular disease
- peritoneal dialysis
- patient reported outcomes
- smoking cessation